http://ipkitten.blogspot.com/2025/06/alnylam-v-moderna-and-judicious-use-of.html
The recent decision of the US Court of Appeal of the Federal Circuit in Alnylam v Moderna relates to the ongoing complex and high-stakes dispute over mRNA vaccine delivery technology. In a blow for Alnylam, the Federal Circuit found that Moderna did not infringe Alnylam’s LNP platform patents in view of a definition of a technical term included in the description that narrowed the
Content reproduced from The IPKat as permitted under the Creative Commons Licence (UK).
